Medscape In Holland, he said physicians still use metformin and a sulfonylurea . If the patient is not at goal with that combination, insulin is added. They are mindful, however, of older or frailer patients who might be vulnerable to hypoglycemia, so the goal ... and more »
Family Practice News Digital Network BARCELONA – It's taken 15 years, but newly released data are finally clearing the last shadow of doubt over metformin's safety in ty...
Clinical Endocrinology News Digital Network ... the investigators randomized patients to receive either 30 mg of albiglutide by injection once a week, sitagliptin (Januvia, a dipeptidyl peptidase–4 inhibitor) at 100 mg orally once per day, glimepiride (Amaryl, a sulfonylurea ) at 2-4 mg orally ...
Wall Street Journal In this assessment of hypoglycemia, patients were analyzed by antidiabetic medication at baseline (not treated with antidiabetic drugs, treated with metformin alone, treated with sulfonylurea , treated with insulin alone or treated with insulin in ...
Yahoo News Data from the study revealed that treatment with dapagliflozin combined with metformin and sulfonylurea significantly reduced glycosylated hemoglobin (HbA1c) levels at 24 weeks compared to those in the placebo arm. The study is evaluating the safety ... and more »
DailyFinance In this assessment of hypoglycemia, patients were analyzed by antidiabetic medication at baseline (not treated with antidiabetic drugs, treated with metformin alone, treated with sulfonylurea , treated with insulin alone or treated with insulin in ... and more »
Dagens Medicin I en studie som presenteras i dag på EASD i Barcelona har brittiska forskare analyserat data för 76 811 patienter som hade fått metformin som förstahandsbehandling och 15 687 patienter som hade fått SU-preparat, sulfonylurea , som förstahandsbehandling.
PharmaTimes All-cause death up 58% with first-line sulfonylurea use. World News | September 26, 2013. Bookmark and Share · Tweet · Kevin Grogan. All-cause death up 58%...
Endocrinology Update The company has requested an Authority Required (streamlined) listing for the combination in the treatment of type 2 diabetes in a patient whose HbA1c is greater than 7% prior to initiation of a DPP-4 inhibitor, a thiazolidinedione or a glucagon-like ...
EIN News (press release) These results provide evidence that canagliflozin may be an effective and generally well-tolerated option that provides glycemic improvements when used with metformin and a sulfonylurea ," said Guillame Charpentier, MD, Head of the Department of ... and more »
